These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 677864)

  • 1. Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.
    Ratzan KR; Baker HB; Lauredo I
    Antimicrob Agents Chemother; 1978 Jun; 13(6):985-7. PubMed ID: 677864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.
    Ratzan KR; Ruiz C; Irvin GL
    Antimicrob Agents Chemother; 1974 Oct; 6(4):426-31. PubMed ID: 4157339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the biliary excretion of different cephalosporins utilizing retrograde cholangio-pancreatography (ERCP).
    Ohnhaus EE; Halter F; Lebek G
    Endoscopy; 1981 Jan; 13(1):31-2. PubMed ID: 7460866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of biliary excretion of cefazolin and other cephalosporins with reference to the relationship between serum levels and administration conditions.
    Nishida M; Murakawa T; Matsubara T; Kohno Y; Yokota Y
    Chemotherapy; 1976; 22(1):30-6. PubMed ID: 1253628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic study of cefazaflur compared to cephalothin and cefazolin.
    Harvengt C; Muenier H; Lamy F
    J Clin Pharmacol; 1977; 17(2-3):128-33. PubMed ID: 833342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
    Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cephalosporins with human and canine serum proteins.
    Peterson LR; Gerding DN
    J Infect Dis; 1978 Apr; 137(4):452-7. PubMed ID: 649989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of absorption and excretion of cefazolin with cephalothin and cephapirin.
    Shimizu T
    Jpn J Antibiot; 1975 Aug; 28(4):542-8. PubMed ID: 1160145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental and clinical study of the biliary excretion of cefamandole (author's transl)].
    Brogard JM; Pinget M; Arnaud JP; Dorner M; Adloff M; Lavillaureix J
    Pathol Biol (Paris); 1981 Jan; 29(1):25-30. PubMed ID: 7010273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biliary tract kinetics of some cephalosporin antibiotics.
    Trachtenberg L; Fagelman KM; Polk HC
    Surgery; 1978 Sep; 84(3):342-7. PubMed ID: 684625
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience in pharmacology in bone and joint surgery with cefamandole and cephalothin.
    Schurman DJ; Moser K; Hirshman HP; Burton DS
    Scand J Infect Dis Suppl; 1980; suppl 25():49-52. PubMed ID: 6937952
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of single doses of cefazolin and cefamandole to penetrate experimental chronic Escherichia coli abdominal abscesses.
    Gerding DN; Kozak AJ; Peterson LR; Hall WH
    Antimicrob Agents Chemother; 1980 Jun; 17(6):1023-9. PubMed ID: 6996611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.
    Lee FH; Pfeffer M; Van Harken DR; Smyth RD; Hottendorf GH
    Antimicrob Agents Chemother; 1980 Feb; 17(2):188-92. PubMed ID: 7387141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative tissue distribution of ceforanide, cefazolin, and cefamandole in rats.
    Lee FH; Smyth RD; Van Harken DR
    Antimicrob Agents Chemother; 1981 Apr; 19(4):625-7. PubMed ID: 7247385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftezole, a new cephalosporin C derivative II. Distribution and excretion in parenteral administration.
    Harada Y; Matsubara S; Kakimoto M; Noto T; Nehashi T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1071-82. PubMed ID: 994326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine after intravenous administration.
    Bergan T
    Chemotherapy; 1977; 23(6):389-404. PubMed ID: 923329
    [No Abstract]   [Full Text] [Related]  

  • 18. The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement.
    Cunha BA; Gossling HR; Pasternak HS; Nightingale CH; Quintiliani R
    J Bone Joint Surg Am; 1977 Oct; 59(7):856-9. PubMed ID: 908715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cephalosporin antibiotics.
    Brogard JM; Comte F; Pinget M
    Antibiot Chemother (1971); 1978; 25():123-62. PubMed ID: 352251
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations in man on some pharmacologic features of cefamandole.
    Grose WE; Bodey GP; Stewart D
    Clin Pharmacol Ther; 1976 Nov; 20(5):579-84. PubMed ID: 975730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.